New Drug Approval Process
After the animal testing stage, FDA decides whether it is reasonably safe for the company to move forward with clinical trials—studies that evaluate the safety and effectiveness of a drug in healthy people and in patients. The drug company submits the results of such studies to FDA for review. The agency conducts a thorough review of the safety and effectiveness data, and considers how the benefits compare to the risks when making a decision of whether or not to approve a drug.
godkännandeprocess (FDA specifik) [SWEDISH]
Ansökan om godkännande (för nytt läkemedel).
2024-01-29
Definitions have been translated into the Swedish language from the following sources: